SSEA-5, an antibody defining a novel surface glycan on human pluripotent stem cells and its application to remove teratoma-forming cells as part of a surface antibody panel

A significant risk in the clinical application of human pluripotent stem cells (hPSCs), including human embryonic and induced pluripotent stem cells (hESCs and hiPSCs), is teratoma formation from residual undifferentiated cells. We have raised a monoclonal antibody (mAb) against hESCs, designated SS...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Tang, Chad, Lee, Andrew S., Volkmer, Jens-Peter, Sahoo, Debashis, Nag, Divya, Mosley, Adriane R., Inlay, Matthew A., Ardehali, Reza, Chavez, Shawn L., Pera, Renee Reijo, Behr, Barry, Wu, Joseph C., Weissman, Irving L., Drukker, Micha
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537836/
https://ncbi.nlm.nih.gov/pubmed/21841799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.1947
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi